Spinal implant manufacturer SI-BONE filed to raise up to $98 million in an initial public offering Sept. 20, according to Renaissance Capital.
Here are four things to know:
1. SI-BONE booked $52 million in revenue for the 12 months ending June 30.
2. Morgan Stanley and Bank of America Merrill Lynch are the deal’s joint bookrunners.
3. Pricing terms were not disclosed.
4. SI-BONE develops the iFuse Implant System, a minimally invasive sacroiliac joint disorder treatment.